Cooling During Chemotherapy – Can Cooling Caps, Gloves, and Socks Prevent Hair Loss and Neuropathy?

Why is cooling used during chemotherapy?

Hair loss and damage to peripheral nerves (peripheral neuropathy) are among the side effects of chemotherapy that can significantly affect patients’ quality of life. For this reason, various methods of local cooling during chemotherapy have been increasingly used in recent years.

The best known are scalp cooling caps, which are used in an attempt to reduce hair loss, and cooling gloves and socks, which are used in an attempt to reduce damage to peripheral nerves in the hands and feet.

At first glance, the principle is quite simple: cold causes blood vessels to constrict and reduces local blood flow. As a result, a smaller amount of chemotherapy may reach the cooled area during the infusion.

This mechanism is also behind one of the most common concerns among patients: if cooling reduces the amount of chemotherapy reaching a particular area, could it also reduce the effectiveness of treatment? The answer is not the same for all cooling methods or all types of cancer.

Cooling caps – can they really prevent hair loss?

Cooling caps, or scalp cooling systems, are used before, during, and for a certain period after chemotherapy administration. Cooling the scalp reduces blood flow through the skin and therefore reduces the exposure of hair follicles to chemotherapy. Cold also reduces the metabolic activity of follicular cells. The result may be less damage to the hair follicles and reduced hair loss.

The method does not work equally well for all patients or with all chemotherapy regimens. Its effectiveness depends on the type and dose of chemotherapy, the combination of drugs used, the temperature and duration of cooling, and individual patient characteristics.

In general, results are better with some regimens containing a group of chemotherapy drugs known as taxanes, while preserving hair may be more difficult with certain regimens containing other groups of drugs, such as anthracyclines. It is therefore important to have realistic expectations: a cooling cap does not guarantee that hair will not fall out, but it can significantly reduce alopecia in some patients.

Is it safe to “shield” the scalp from chemotherapy?

One of the earlier concerns regarding the use of cooling caps was that reduced blood flow to the scalp could also mean reduced exposure of this area to chemotherapy. Theoretically, this raised the question of whether any tumor cells present in the scalp might therefore be less exposed to treatment and whether the scalp could become a kind of “sanctuary site” for the development of metastases.

However, it is important to emphasize that scalp metastases are generally very rare, regardless of the use of cooling caps. Studies to date have not shown that scalp cooling increases the risk of developing scalp metastases. A large recent meta-analysis estimated the incidence of scalp metastases among patients using scalp cooling at approximately 0.15%. Therefore, this initially largely theoretical concern has not been shown to represent a clinically significant problem.

Based on currently available evidence, scalp cooling is considered oncologically safe in appropriately selected patients with solid tumors. However, this does not mean that it is suitable for every patient or every type of malignancy, and the decision to use it should be made in the context of the type of cancer and the chemotherapy being administered.

What do cooling gloves and socks do?

Here, the goal is quite different. Certain chemotherapy drugs can damage peripheral nerves and cause chemotherapy-induced peripheral neuropathy (CIPN).

It most commonly manifests as:

• tingling in the fingers and toes

• numbness

• burning sensations

• pain

• increased or decreased sensitivity

• a sensation of “walking on cotton”

• difficulty with fine motor tasks, such as fastening buttons

• in more severe cases, problems with walking and balance.

Neuropathy is a particularly important side effect of taxanes such as paclitaxel and docetaxel, platinum compounds, particularly oxaliplatin, and certain other chemotherapy drugs.

Unlike many other side effects of chemotherapy, neuropathy can persist for months and, in some patients, even years after treatment has ended.

How is cooling the hands and feet supposed to help?

The principle is similar to scalp cooling. Cooling gloves and socks lower the temperature of the hands and feet and cause vasoconstriction. The assumption is that this reduces the amount of chemotherapy reaching the peripheral nerves in these areas during the infusion.

The most distal parts of the extremities are typically where chemotherapy-induced neuropathy first develops. This makes the concept particularly appealing: temporarily reducing the exposure of peripheral nerves to chemotherapy specifically during its administration.

Do cooling gloves and socks work?

The answer is somewhat less clear-cut than with scalp cooling. A number of studies have shown promising results, particularly in patients receiving taxanes.

In some studies, patients who cooled their hands and feet during paclitaxel treatment experienced fewer symptoms of neuropathy than those who did not use cooling. More recent data continue to suggest a potential benefit.

However, the quality and size of the studies are not yet sufficient to consider cryotherapy a proven standard for preventing neuropathy. Current ASCO guidelines therefore state that no formal recommendation can yet be made for cryotherapy in the prevention of chemotherapy-induced peripheral neuropathy, although preliminary evidence suggests a possible benefit and the method generally appears to be reasonably safe.

In other words, cooling has not been proven to reliably prevent neuropathy, but the results are sufficiently promising to justify further research and its use in clinical practice at some centers.

Is cooling the hands and feet dangerous?

Most patients tolerate cooling without serious problems, but it is not entirely without risk.

Possible side effects include:

• discomfort from the cold

• pain

• numbness

• changes in skin color

• severe intolerance to cold

• rarely, skin damage caused by excessive cooling.

The goal is therefore not “the colder, the better.” Uncontrolled use of extremely cold or frozen packs is not the same as controlled medical cooling.

Particular caution is required in people with circulatory disorders or other conditions in which exposing the extremities to intense cold may pose a risk.

What about oxaliplatin?

There is an important distinction in this case. Oxaliplatin can cause a characteristic acute cold-induced neuropathy. After treatment, patients are often advised to avoid cold drinks, cold air, and touching very cold objects for several days. For this reason, the use of conventional cooling gloves and socks cannot simply be extrapolated from experience with paclitaxel to oxaliplatin.

Different cooling approaches have also been studied with oxaliplatin, but this is a different situation, and in general patients should not use cooling on their own simply because it may help prevent neuropathy associated with some other chemotherapy drugs.

Can cooling reduce the effectiveness of chemotherapy?

This is an understandable concern. The purpose of local cooling is precisely to temporarily reduce the exposure of certain peripheral tissues to chemotherapy. Therefore, the theoretical question of whether this could affect oncological safety is legitimate.

With scalp cooling, there is now considerable clinical experience, and available data in appropriately selected patients with solid tumors have not shown a significant increase in the risk of scalp metastases.

With cooling of the hands and feet, the area being cooled is relatively small, and the method is being investigated specifically as a way of reducing local neurotoxicity without affecting the systemic effectiveness of chemotherapy.

However, the fact that something makes theoretical sense is not sufficient to consider it a proven standard. It is therefore important to distinguish between methods for which we already have strong clinical evidence and those that are still being investigated.

Can neuropathy be prevented with medication or vitamins?

At present, there is no medication or dietary supplement that can reliably prevent chemotherapy-induced peripheral neuropathy. Various vitamins, minerals, antioxidants, and other preparations have been studied for years, but most have not demonstrated sufficiently convincing benefits to be routinely recommended.

ASCO currently does not recommend any medication for the routine prevention of CIPN. This is important because patients are often offered various “neuroprotective” supplements during chemotherapy.

What if neuropathy develops despite preventive measures?

The most important thing is not to wait until symptoms become severe. Tingling, numbness, burning sensations, or problems with fine motor skills should be reported to the oncologist as soon as they appear.

With some treatments, the development of significant neuropathy may require a dose adjustment, treatment delay, or a change in therapy. The aim is to find the right balance between maintaining the effectiveness of cancer treatment and minimizing the risk of permanent nerve damage.

For established painful chemotherapy-induced neuropathy, duloxetine currently has the strongest evidence of effectiveness, although its benefit is not complete.

So – should cooling caps, gloves, and socks be used or not?

There is no need to be either “for” or “against” cooling as a single concept, because these are different interventions supported by different levels of evidence.

Scalp cooling is now an established method that can reduce hair loss caused by certain chemotherapy regimens in appropriately selected patients. Its effectiveness varies between treatment protocols, but available evidence generally supports its safety.

Cooling of the hands and feet to prevent neuropathy is a very interesting approach, particularly in patients receiving taxanes. Some studies have shown positive results, but the evidence is not yet strong enough for cryotherapy to be considered a universal standard for preventing neuropathy.

The overall conclusion regarding effectiveness and safety is: depending on the chemotherapy you are receiving, cooling may be worthwhile, but it should be discussed with your oncologist and performed appropriately. It is not a miraculous way to prevent side effects, but neither is it a method that should be dismissed outright.

Frequently asked questions

How long should cooling gloves and socks be worn?

There is no single universal protocol. In studies involving taxanes, cooling is most commonly started 15–30 minutes before chemotherapy, continued throughout the infusion, and maintained for another 15–30 minutes afterwards. With gel-based gloves, they may need to be replaced during longer infusions to maintain an appropriate temperature. The exact duration should be adapted to the drug being administered and the cooling system being used.

Can I use ordinary frozen gloves or ice packs?

Uncontrolled application of very cold or frozen objects directly to the skin is not recommended. Excessive cooling can cause pain and skin damage. Clinical protocols use specially designed cooling gloves and socks, with skin condition and tolerance being monitored. A thin cotton layer may be placed between the skin and frozen gel. Cooling should be stopped if severe pain, pronounced numbness, or changes in skin color occur.

With which chemotherapy drugs do cooling gloves and socks make the most sense?

Most of the available evidence relates to taxanes, particularly paclitaxel and docetaxel. Cryotherapy has been studied most extensively with these drugs as a potential method of preventing peripheral neuropathy, and more recent sources describe it as a promising or likely effective intervention.

Results from taxane studies cannot automatically be applied to other neurotoxic chemotherapy drugs. Oxaliplatin is particularly distinctive because cold itself can trigger acute neurological symptoms, and there is currently insufficient evidence to make a firm recommendation for routine cooling of the extremities in this setting.

Does this mean cooling gloves will definitely prevent neuropathy?

No. This is an important distinction. Some studies have shown a lower incidence or severity of neuropathy with cooling, but results have not been completely consistent, and the studies have used different temperatures, cooling durations, and techniques. Cooling should therefore be regarded as a possible preventive measure, not a guarantee that neuropathy will not develop. Published ASCO guidelines were unable to make a formal recommendation for or against cryotherapy because of the limited quality of evidence, although more recent data further support its potential benefit.

If I develop tingling, should I wait until my next appointment?

No. New tingling, numbness, burning, pain, or reduced dexterity in the hands or feet should be reported to the oncology team as early as possible. Neuropathy can be cumulative, meaning that it may worsen with subsequent cycles of chemotherapy. Early recognition allows the oncology team to assess whether treatment can continue unchanged or whether the dose or treatment schedule should be adjusted.

Will my hair still fall out if I use a cooling cap?

It may. Scalp cooling reduces the risk and extent of hair loss, but cannot completely prevent it in every patient. Its effectiveness also depends on the type of chemotherapy. Some patients preserve most of their hair, others experience thinning, while some may still experience substantial hair loss despite cooling.

How long is a cooling cap worn?

Cooling begins before chemotherapy is administered, continues throughout the infusion, and is maintained for a period afterwards. The exact duration depends on the chemotherapy regimen and the cooling system being used. In published protocols, pre-cooling commonly lasts around 20–45 minutes, while post-infusion cooling may continue from approximately 20 minutes to several hours, depending on the drug and cooling system.

Does it make sense to start using a cooling cap after several chemotherapy cycles?

If the aim is to reduce hair loss, scalp cooling should ideally begin with the first chemotherapy treatment. Once a significant amount of hair has already been lost as a result of previous cycles, cooling cannot reverse that hair loss.